150 related articles for article (PubMed ID: 24145197)
21. EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.
Pellegrino R; Calvisi DF; Neumann O; Kolluru V; Wesely J; Chen X; Wang C; Wuestefeld T; Ladu S; Elgohary N; Bermejo JL; Radlwimmer B; Zörnig M; Zender L; Dombrowski F; Evert M; Schirmacher P; Longerich T
Hepatology; 2014 May; 59(5):1886-99. PubMed ID: 24285179
[TBL] [Abstract][Full Text] [Related]
22. Drosophila p53-related protein kinase is required for PI3K/TOR pathway-dependent growth.
Ibar C; Cataldo VF; Vásquez-Doorman C; Olguín P; Glavic A
Development; 2013 Mar; 140(6):1282-91. PubMed ID: 23444356
[TBL] [Abstract][Full Text] [Related]
23. [Cellular senescence and the myth of Janus].
Brondello JM; Prieur A; Philipot D; Lemaitre JM; Lenaers G; Piette J; Dulić V
Med Sci (Paris); 2012 Mar; 28(3):288-96. PubMed ID: 22480653
[TBL] [Abstract][Full Text] [Related]
24. Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.
Schmid G; Kramer MP; Maurer M; Wandl S; Wesierska-Gadek J
J Cell Biochem; 2007 Aug; 101(6):1355-69. PubMed ID: 17471501
[TBL] [Abstract][Full Text] [Related]
25. Artificial regulation of p53 function by modulating its assembly.
Inobe T; Nozaki M; Nukina N
Biochem Biophys Res Commun; 2015 Nov; 467(2):322-7. PubMed ID: 26454170
[TBL] [Abstract][Full Text] [Related]
26. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming.
Eng CH; Abraham RT
Oncogene; 2011 Nov; 30(47):4687-96. PubMed ID: 21666712
[TBL] [Abstract][Full Text] [Related]
27. Aging, the new frontier for science.
Shoaib M
J Pak Med Assoc; 2013 Sep; 63(9):1217. PubMed ID: 24601215
[No Abstract] [Full Text] [Related]
28. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
Feng Z; Hu W; de Stanchina E; Teresky AK; Jin S; Lowe S; Levine AJ
Cancer Res; 2007 Apr; 67(7):3043-53. PubMed ID: 17409411
[TBL] [Abstract][Full Text] [Related]
29. P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.
Batisse-Lignier M; Sahut-Barnola I; Tissier F; Dumontet T; Mathieu M; Drelon C; Pointud JC; Damon-Soubeyrand C; Marceau G; Kemeny JL; Bertherat J; Tauveron I; Val P; Martinez A; Lefrançois-Martinez AM
Oncogene; 2017 Aug; 36(31):4445-4456. PubMed ID: 28368424
[TBL] [Abstract][Full Text] [Related]
30. p53 regulates autophagic activity in senescent rat mesenchymal stromal cells.
Zheng Y; Lei Y; Hu C; Hu C
Exp Gerontol; 2016 Mar; 75():64-71. PubMed ID: 26792455
[TBL] [Abstract][Full Text] [Related]
31. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.
Rieker C; Engblom D; Kreiner G; Domanskyi A; Schober A; Stotz S; Neumann M; Yuan X; Grummt I; Schütz G; Parlato R
J Neurosci; 2011 Jan; 31(2):453-60. PubMed ID: 21228155
[TBL] [Abstract][Full Text] [Related]
32. Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
Stanga S; Lanni C; Govoni S; Uberti D; D'Orazi G; Racchi M
Aging (Albany NY); 2010 Sep; 2(9):545-54. PubMed ID: 20876941
[TBL] [Abstract][Full Text] [Related]
33. Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.
Chen SS; Chang PC; Cheng YW; Tang FM; Lin YS
EMBO J; 2002 Sep; 21(17):4491-9. PubMed ID: 12198151
[TBL] [Abstract][Full Text] [Related]
34. Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope.
Castedo M; Roumier T; Blanco J; Ferri KF; Barretina J; Tintignac LA; Andreau K; Perfettini JL; Amendola A; Nardacci R; Leduc P; Ingber DE; Druillennec S; Roques B; Leibovitch SA; Vilella-Bach M; Chen J; Este JA; Modjtahedi N; Piacentini M; Kroemer G
EMBO J; 2002 Aug; 21(15):4070-80. PubMed ID: 12145207
[TBL] [Abstract][Full Text] [Related]
35. Faithfull modeling of PTEN loss driven diseases in the mouse.
Nardella C; Carracedo A; Salmena L; Pandolfi PP
Curr Top Microbiol Immunol; 2010; 347():135-68. PubMed ID: 20549475
[TBL] [Abstract][Full Text] [Related]
36. Hormesis does not make sense except in the light of TOR-driven aging.
Blagosklonny MV
Aging (Albany NY); 2011 Nov; 3(11):1051-62. PubMed ID: 22166724
[TBL] [Abstract][Full Text] [Related]
37. The molecular perspective: p53 tumor suppressor.
Goodsell DS
Stem Cells; 1999; 17(3):189-90. PubMed ID: 10342561
[No Abstract] [Full Text] [Related]
38. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease.
Santos RX; Correia SC; Cardoso S; Carvalho C; Santos MS; Moreira PI
J Neurochem; 2011 Jun; 117(6):927-36. PubMed ID: 21447003
[TBL] [Abstract][Full Text] [Related]
39. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
40. Linking mitochondrial dynamics to mitochondrial protein quality control.
Haroon S; Vermulst M
Curr Opin Genet Dev; 2016 Jun; 38():68-74. PubMed ID: 27235806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
